Stankovic Srdjan R. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Feb 25, 2022
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2022-02-23$23.80/sh−1,501$35,724→ 48,437 total - Exercise/Conversion
Restricted Stock Units
2022-02-23+4,919→ 14,758 total→ Common Stock (4,919 underlying) - Exercise/Conversion
Common Stock
2022-02-23+4,919→ 49,938 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning February 23 2022.